Bibliography
- CYRUS T, WINTER PM, CARUTHERS SD, WICKLINE SA, LANZA GM: Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy. Expert Rev. Cardiovasc. Ther. (2005) 3:705-715.
- UWATOKU T, SHIMOKAWA H, ABE K et al.: Application of nanoparticles technology for the prevention of restenosis after balloon injury in rats. Circ. Res. (2003) 92:e62-e69.
- NANAI S, CHORNY M, GERTZ AD et al.: Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials (2005) 26:451-461.
- PANDEY R, KHULLER GK: Antitubercular inhaled therapy: opportunities, progress and challenges. J. Antimicrob. Chemother. (2005) 55:430-435.
- PANDEY R, SHARMA A, ZAHOOR A, SHARMA S, KHULLER GK, PRASAD B: Poly (d,l-lactide-co-glycolide) nanoparticles-based inhalable sustained drug delivery system for experimental tuberculosis. J. Antimicrob. Chemother. (2003) 52:981-986.
- ZHANG W, YANG H, MOHAPATRA S et al.: Inhibition of respiratory synctial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. (2005) 11:56-62.
- KONSTAN MW, DAVIS PB, WAGENER JS et al.: Compacted DNA nanoparticles administered to the nasal mucosa of cystric fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum. Gene Ther. (2005) 15:1255-1269.
- OTSUBO T, MAESAKI S, HOSSAIN MS et al.: In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus. Antimicrob. Agents Chemother. (1999) 43:471-475.
- DINAUER N, BALTHASAR S, WEBER C, KREUTER J, LANGER K, VON BRIESEN H: Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. Biomaterials (2005) 26:5898-5906.
- WANG X, UTO T, SATO K et al.: Potent activation of antigen-specific T cells by antigen-loaded nanospheres. Immunol. Lett. (2005) 98:123-130.